Array
(
[id] => 2679982
[patent_doc_number] => 05004697
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-04-02
[patent_title] => 'Cationized antibodies for delivery through the blood-brain barrier'
[patent_app_type] => 1
[patent_app_number] => 7/085627
[patent_app_country] => US
[patent_app_date] => 1987-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 3239
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/004/05004697.pdf
[firstpage_image] =>[orig_patent_app_number] => 085627
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/085627 | Cationized antibodies for delivery through the blood-brain barrier | Aug 16, 1987 | Issued |
Array
(
[id] => 2603611
[patent_doc_number] => 04931546
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1990-06-05
[patent_title] => 'Process for the treatment of collagen, notably for facilitating its cross-linking, and the collagen obtained by the application of the said process'
[patent_app_type] => 1
[patent_app_number] => 7/072368
[patent_app_country] => US
[patent_app_date] => 1987-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3696
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/931/04931546.pdf
[firstpage_image] =>[orig_patent_app_number] => 072368
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/072368 | Process for the treatment of collagen, notably for facilitating its cross-linking, and the collagen obtained by the application of the said process | Jul 12, 1987 | Issued |
Array
(
[id] => 2386000
[patent_doc_number] => 04753794
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1988-06-28
[patent_title] => 'Use of mullerian inhibiting substance as a contraceptive agent'
[patent_app_type] => 1
[patent_app_number] => 6/877735
[patent_app_country] => US
[patent_app_date] => 1986-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4564
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/753/04753794.pdf
[firstpage_image] =>[orig_patent_app_number] => 877735
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/877735 | Use of mullerian inhibiting substance as a contraceptive agent | Jun 23, 1986 | Issued |